Incidence trend of type 2 diabetes from 2012 to 2021 in Germany: an analysis of health claims data of 11 million statutorily insured people
Open accessThe DOI matches its Crossref record; 44 of the 44 references it cites were found in a registry or an index.
Abstract
AIMS/HYPOTHESIS: The aim of the study is to describe the time trend of type 2 diabetes incidence in the largest state of Germany, Bavaria, from 2012 to 2021, and to compare the incidence rates during the pandemic period (2020-2021) to the pre-pandemic period (2012-2019). METHODS: This secondary data analysis uses health claims data provided by the Bavarian Association of Statutory Health Insurance Physicians (KVB), covering approximately 11 million insurees, accounting for 85% of the total population of Bavaria, Germany. Newly diagnosed type 2 diabetes cases in adults (≥20 years) coded as E11 (Diabetes mellitus, Type 2) or E14 (Unspecified diabetes mellitus) under ICD-10, German modification (ICD-10-GM) for the study period 2012 to 2021 were included. Annual and quarterly age-standardised incidence rates (ASIR) stratified by sex, age and region were calculated using the European standard population. Sex-specific crude incidence rates (CIR) were calculated using 10-year age groups. Regression analyses adjusted for time trends, seasonal effects, and pandemic effects were used to analyse the incidence trend and to assess the effect of the pandemic. RESULTS: Overall, 745,861 new cases of type 2 diabetes were diagnosed between 2012 and 2021: 50.4% (376,193 cases) in women. The male/female ratio remained stable over the observation period, while the median age at diagnosis decreased from 61 to 58 years in men and from 66 years to 61 years in women. ASIR were consistently higher for men compared with women, with the yearly difference remaining stable over time (2012: 18%; 2021: 20%). An overall decreasing trend in ASIR was observed during the study period, with a strong decrease from 2012 to 2017, followed by a less pronounced decline from 2018 to 2021 for both sexes. For men, ASIR decreased from 1514 per 100,000 person-years in 2012 to 995 per 100,000 person-years in 2021 (4.6% average annual reduction), and for women from 1238 per 100,000 person-years in 2012 to 796 per 100,000 person-years in 2021 (4.8% average annual reduction). This downward trend was also observed for age groups above 50 years. Regression analyses showed no significant change in incidence rates during the pandemic period (2020 and 2021) compared with the pre-pandemic period. CONCLUSIONS/INTERPRETATION: For the first time, a 10-year incidence trend of type 2 diabetes is reported for Germany, showing a strong decline from 2012 to 2017, followed by a less pronounced decline from 2018 to 2021. The incidence trend of type 2 diabetes appears not to have been affected by the first 2 years of the COVID-19 pandemic. Despite an overall increasing prevalence, the incidence is decreasing, potentially resulting from robust screening by family physicians, reducing the median age at diagnosis by 3 to 5 years. However, further investigation is needed to fully identify the reasons for the declining incidence trend. Continued incidence monitoring is necessary to identify the long-term trend and the potential effect of the pandemic on diagnoses of type 2 diabetes.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures




Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“conditions more frequently diagnosed or discussed during this stage of life [38,39].”
From Sociodemographic differences in dementia prevention knowledge in Germany: Implications for targeted health communication (2026) · cites this paper as [38]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“while diabetes [38], higher alcohol consumption [49], and reduced social activity [50] are more prevalent in men [10].”
From Sociodemographic differences in dementia prevention knowledge in Germany: Implications for targeted health communication (2026) · cites this paper as [38]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Wickham, H. (2016) · Use R! · doi:10.1007/978-3-319-24277-4 · Cited by 33,115
Wickham, H., Averick, M., Bryan, J., Chang, W., McGowan, L., François, R., Grolemund, G., Hayes, A., Henry, L., Hester, J., et al. (2019) · Journal of Open Source Software · doi:10.21105/joss.01686 · Cited by 22,138 · cited 1×
“All analyses were conducted in R [14], using the tidyverse framework for data management and the ggplot2 package for creating graphics [15, 16].”
Saeedi, P., Petersohn, I., Salpea, P., Malanda, B., Karuranga, S., Unwin, N., Colagiuri, S., Guariguata, L., Motala, A. A., Ogurtsova, K., et al. (2019) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2019.107843 · Cited by 10,792
Interrupted time series regression for the evaluation of public health interventions: a tutorial
Lopez Bernal, J., Cummins, S., & Gasparrini, A. (2016) · International Journal of Epidemiology · doi:10.1093/ije/dyw098 · Cited by 3,049 · cited 2×
“An interrupted time series regression analysis was used to quantify the incidence trend over time and assess a possible pandemic effect by using three different prediction models for ASIR per 100,000 person-years [13].”
MethodChatterjee, S., Khunti, K., & Davies, M. J. (2017) · The Lancet · doi:10.1016/s0140-6736(17)30058-2 · Cited by 2,577 · cited 1×
“However, type 2 diabetes often develops slowly over the course of several years [41], delaying the direct impact of the pandemic on incidence.”
Sex differences in type 2 diabetes
Kautzky-Willer, A., Leutner, M., & Harreiter, J. (2023) · Diabetologia · doi:10.1007/s00125-023-05891-x · Cited by 624
US Preventive Services Task Force, Davidson, K. W., Barry, M. J., Mangione, C. M., Cabana, M., Caughey, A. B., Davis, E. M., Donahue, K. E., Doubeni, C. A., Krist, A. H., et al. (2021) · JAMA · doi:10.1001/jama.2021.12531 · Cited by 480 · cited 3×
“Therefore, screening for type 2 diabetes seems to be an important step in diabetes prevention since cost-effective interventions (pharmacological and behavioural interventions) show benefits in preventing or delaying the progression of diabetes [35].”
BackgroundGute Praxis Sekundärdatenanalyse (GPS): Leitlinien und Empfehlungen
Swart, E., Gothe, H., Geyer, S., Jaunzeme, J., Maier, B., Grobe, T., & Ihle, P. (2015) · Das Gesundheitswesen · doi:10.1055/s-0034-1396815 · Cited by 445 · cited 1×
“This study was conducted in accordance with the ‘Good Practice of Secondary Data Analysis’ guideline [10].”
MethodPrediabetes and what it means: the epidemiological evidence
Echouffo-Tcheugui, J. B., & Selvin, E. (2021) · Annual Review of Public Health · doi:10.1146/annurev-publhealth-090419-102644 · Cited by 406 · cited 2×
“Additionally, lifestyle interventions also reduce the progression of diabetes [35, 36].”
Trends in incidence of total or type 2 diabetes: systematic review
Magliano, D. J., Islam, R. M., Barr, E. L. M., Gregg, E. W., Pavkov, M. E., Harding, J. L., Tabesh, M., Koye, D. N., & Shaw, J. E. (2019) · BMJ · doi:10.1136/bmj.l5003 · Cited by 346 · cited 4×
“But incidence should also become a standard reporting metric for diabetes, since unlike prevalence, it allows the direct assessment of the effects of changes in risk factors, as it is not influenced by other factors, such as survival [17].”
Influential
Research works printed but not linked: 2
- International Diabetes Federation (2021) IDF Diabetes Atlas, 10th edn. International Diabetes Federation, Brussels, Belgium
- Pace M, Lanzieri G, Glickman M et al (2013) Revision of the European standard population. Eurostat Methodologies and Working Papers. 10.2785/11470 · doi:10.2785/11470
Cited by
Young‐onset type 2 diabetes—Epidemiology, pathophysiology, and management
Luk, A. O. Y., Wu, H., Fan, Y., Fan, B., O, C. K., & Chan, J. C. N. (2025) · Journal of Diabetes Investigation · doi:10.1111/jdi.70081 · Cited by 13
“In Bavaria, Germany, the incidence of type 2 diabetes was stable in individuals younger than 50 years but declined in those older than 50 years between 2012 and 2021 23 .”
Chen, M., Dou, C., Ye, C., Kong, L., Xu, M., Xu, Y., Li, M., Zhao, Z., Zheng, J., Lu, J., et al. (2025) · Diabetes Obesity and Metabolism · doi:10.1111/dom.16173 · Cited by 10
Schmitz, T., Freuer, D., Linseisen, J., & Meisinger, C. (2024) · Clinical Nutrition · doi:10.1016/j.clnu.2024.11.004 · Cited by 5
“This is mainly in accordance with known differences in comorbidities and life-style habits in the general German population [43,44], but the variation between men and women might be more pronounced in our study sample.”
Mertens, P. R., Kanaan, M. R., Abou-Watfa, A. A., Bender, S. T., Wiech, T., Gröne, H., & Scurt, F. G. (2025) · BMC Nephrology · doi:10.1186/s12882-025-04617-y · Cited by 4
Koch-Institut, R. (2025) · Europe PMC (PubMed Central) · doi:10.25646/13381 · Cited by 3
“Another study found no significant difference in incidence rates in the 2020 to 2021 pandemic phase compared to the 2012 to 2019 pre-pandemic phase, but did observe a less pronounced decline in incidence in the 2018 to 2021 period compared to the 2012 to 2017 period [ 17 ].”
InfluentialType 2 diabetes in Norway 2009–2021: Have declining incidence rates continued?
Hindenes, L. B., Ruiz, P. L., Tapia, G., Bakken, I. J., Qvigstad, E., Gulseth, H. L., & Stene, L. C. (2026) · Diabetic Medicine · doi:10.1111/dme.70225 · Cited by 2
Sarabhai, T., Mathew, A., Rashidi‐Alavijeh, J., Willuweit, K., Gallinat, A., & Führer, D. (2026) · Deutsches Ärzteblatt international · doi:10.3238/arztebl.m2026.0019 · Cited by 2
Clinical and genomic profiling of Klebsiella pneumoniae in liver abscesses
Aurnhammer, F., Baltzer, M. M., Butt, J., Marr, L. S., Rath, A., Kieninger, B., Schneider‐Brachert, W., Utpatel, C., Niemann, S., Steinmann, E., et al. (2026) · Virulence · doi:10.1080/21505594.2026.2670805 · Cited by 2
“In addition, the estimated average age for DM diagnosis is around 61 y, which is roughly equivalent to the median age of 69 y observed in our patient cohort [67].”
Albus, P., Folkerts, A.-K., Kessler, J., Köhler, S., & Kalbe, E. (2026) · The journal of prevention of Alzheimer's disease · doi:10.1016/j.tjpad.2026.100517 · Cited by 1
“Women are more frequently affected by factors such as lower educational attainment, depression, and insufficient physical activity [10], while diabetes [38], higher alcohol consumption [49], and reduced social activity [50] are more prevalent in men [10].”
Nilsson, P. M., & Vaag, A. A. (2024) · Diabetologia · doi:10.1007/s00125-024-06195-4 · Cited by 1
Piedboeuf-Potyka, K., Hering, R., Schulz, M., Mackowiak, M., Brinks, R., Kuß, O., Hoyer, A., & Tönnies, T. (2025) · BMJ Open · doi:10.1136/bmjopen-2024-094824 · Cited by 3
Lehner, C. T., Schauberger, G., & Klug, S. J. (2024) · Diabetologia · doi:10.1007/s00125-024-06255-9 · Cited by 1
Self-citationSchederecker, F., Lehner, C. T., Eberl, M., Schauberger, G., Hansmann, K., Donnachie, E., Tauscher, M., König, A., Sundmacher, L., & Klug, S. J. (2024) · Heart · doi:10.1136/heartjnl-2024-324181
Self-citationBengoa-Urrengoechea, I., Malo, S., Rabanaque, M. J., Sánchez-Calavera, M. A., & Aguilar‐Palacio, I. (2026) · Healthcare · doi:10.3390/healthcare14172804
“Face-to-face visits with GPs and nurses may contribute to a greater awareness of clinical parameters and reinforce the importance of lifestyle modification, which may be more difficult to achieve through remote care alone [12,18,25,27,30,35,38].”
Zakic, K., Freuer, D., Linseisen, J., & Christa, M. (2026) · Diabetology & Metabolic Syndrome · doi:10.1186/s13098-026-02096-1
“The role of hepatocyte growth factor in the relationship between body fat distribution and plasma markers of glucose metabolism: a cross-sectional study Background Diabetes is a global public health crisis, associated with high morbidity, mortality, and economic costs [1, 2].”
Kostev, K., Sievert, H., Konrad, M., & Sarabhai, T. (2026) · Diabetes Obesity and Metabolism · doi:10.1111/dom.71089
Brunner, P., Papukchieva, S., Friedrich, B., Steinmetz‐Späh, J., Hammer, M., Kienhöfer, J., Ebert, T., & Lautenbach, A. (2026) · Frontiers in Digital Health · doi:10.3389/fdgth.2026.1824377
Andreasson, J., Dietler, D., Björk, J., & Bennet, L. (2026) · BMC Public Health · doi:10.1186/s12889-026-30127-z
“…from England indicated a return to pre-pandemic trends in type 2 diabetes in 2022 after initial increase during the first two years of the pandemic [12], while a German study showed no change in type 2 diabetes incidence during the first two pandemic years compared to the pre-pandemic period [13].”
Metadata
- Authors
- Lehner, C. T., Eberl, M., Donnachie, E., Tanaka, L. F., Schauberger, G., Schederecker, F., Himmler, S., Sundmacher, L., & Klug, S. J.
- Affiliations
- Technical University of Munich (DE)
- Corresponding author
- Klug, Stefanie J.
- ORCID
- Venue
- Diabetologia
- Published
- 2024-02-26
- Volume
- 67
- Issue
- 6
- Pages
- 1040-1050
- ISSN
- 0012-186X (ISSN-L)
- 1432-0428
- PMC
- PMC11058936
- OpenAlex
- W4392159140
- Cited by
- 18
- References
- 44
- Citations by year
- 2026: 8 · 2025: 6 · 2024: 4
- FWCI
- 5.93
- Type
- journal article
- Language
- en
- Update notices
- correction (2025-06-17)
- Open access
- hybrid
- doi.org
- Licence
- cc-by
- creativecommons.org/licenses/by/4.0 (tdm)
- creativecommons.org/licenses/by/4.0 (vor)
- Locations
- Diabetologia (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- PUBLISSO (German National Library of Medicine) (submittedVersion, cc-by)
- mediaTUM – the media and publications repository of the Technical University Munich (Technical University Munich) (submittedVersion)
- Funders
- Deutsche Forschungsgemeinschaft (458556631)
- Technische Universität München
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
- Keywords
- type 2 diabetes, incidence trends, COVID-19 pandemic, sex differences, age at diagnosis, Bavaria, statutory health insurance claims, age-standardized incidence rate, sex ratio, seasonal variation, regional variation, health insurance claims data, underdiagnosis in women
- MeSH terms
- COVID-19, Adult, Aged, Aged, 80 and over, Diabetes Mellitus, Type 2, Female, Germany, Humans, Insurance, Health, Male, Middle Aged, Incidence, Young Adult, Pandemics
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.